South Korea
· Delayed Price · Currency is KRW DuChemBIO Co.,Ltd. Company Description
DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.
Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amyloid in Alzheimer's disease.
The company also offers FES, a solution for diagnosis of metastatic breast cancer and determination of estrogen receptor status; FACBC for prostate cancer diagnosis; FDG for the diagnosis of tumors; and NaF for the diagnosis of bone-related diseases.
DuChemBIO Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.
| Country | South Korea |
| Founded | 2002 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
Contact Details
Address: 81, Wausan-ro Seoul, 04041 South Korea | |
| Phone | 82 2 332 4868 |
| Website | duchembio.com |
Stock Details
| Ticker Symbol | 176750 |
| Exchange | KOSDAQ |
| Reporting Currency | KRW |
| SIC Code | 3842 |